Close

Recro Pharma (REPH) Announces CRL from FDA for IV meloxicam NDA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/18/2024

1. LVS
2. TSM
3. SPY
4. NFLX
5. CSX
6. UAL
7. ALK
8. EFX
9. TSLA
10. MU


Go back to Recro Pharma (REPH) Announces CRL from FDA for IV meloxicam NDA
RECRO PHARMA (NASDAQ: REPH) Delayed: 2.09 --0 (-0%)
Previous Close $2.09    52 Week High $12.50 
Open $2.09    52 Week Low $5.59 
Day High $2.09    P/E N/A 
Day Low $2.09    EPS $0.00 
Volume 145,743